Page last updated: 2024-08-24

naphthalimides and Colorectal Neoplasms

naphthalimides has been researched along with Colorectal Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (50.00)18.2507
2000's0 (0.00)29.6817
2010's4 (40.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Dai, F; Feng, Y; Gao, L; Ge, C; Wang, C; Wang, S; Wang, Y; Xie, S; Xu, X; Zhang, K; Zhang, Z; Zhao, Y1
Blagojevic, B; Cheng, X; Dabiri, Y; Ott, I; Schmid, A; Streciwilk, W; Theobald, J; Wölfl, S1
Cheng, Z; Li, Q; Liang, X; Liu, J; Qian, X; Wang, Z; Xu, Y; Yin, P; Zhu, H1
Alcala, MA; Bartlett, DL; Kwan, SY; Lang, M; Lee, YJ; Petoud, S; Shade, CM; Uh, H; Wang, M; Weber, SG1
Li, JH; Li, Q; Wang, CJ; Wang, JH; Xie, SQ; Zhang, YH; Zhao, J1
Burch, PA; Kovach, JS; Marschke, RF; O'Connell, MJ; Rubin, J; Schutt, AJ; Wieand, HS1
Brown, TD; Craig, JB; Einstein, AB; Fleming, T; Goodman, PJ; Macdonald, JS1
Abad, A; Benavides, A; Díaz-Puente, MT; Fabregat, X; Font, A; Grávalos, C; Martín, M; Molina, F1
Comis, RL; Hudes, GR; O'Dwyer, PJ; Ozols, RF; Paul, AR; Walczak, J1
Depisch, D; Haider, K; Kornek, G; Scheithauer, W1

Trials

4 trial(s) available for naphthalimides and Colorectal Neoplasms

ArticleYear
Advanced colorectal adenocarcinoma: treatment with amonafide.
    Journal of the National Cancer Institute, 1994, Jun-15, Volume: 86, Issue:12

    Topics: Adenine; Antineoplastic Agents; Carcinoma; Colorectal Neoplasms; Humans; Imides; Intercalating Agents; Isoquinolines; Naphthalimides; Organophosphonates

1994
Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group study.
    Anti-cancer drugs, 1993, Volume: 4, Issue:1

    Topics: Adenine; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates

1993
Phase II study of Mitonafide in advanced and relapsed colorectal cancer.
    Investigational new drugs, 1996, Volume: 14, Issue:2

    Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides

1996
Phase II study of amonafide (nafidamide, NSC 308847) in advanced colorectal cancer.
    Investigational new drugs, 1991, Volume: 9, Issue:1

    Topics: Adenine; Adenocarcinoma; Antineoplastic Agents; Colorectal Neoplasms; Drug Evaluation; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Organophosphonates

1991

Other Studies

6 other study(ies) available for naphthalimides and Colorectal Neoplasms

ArticleYear
Suppression of oxidative phosphorylation and IDH2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantrone.
    Cancer letters, 2021, 10-28, Volume: 519

    Topics: Animals; Antioxidants; Autophagy; Cell Death; Cell Line, Tumor; Citric Acid Cycle; Colorectal Neoplasms; Down-Regulation; HCT116 Cells; HT29 Cells; Humans; Isocitrate Dehydrogenase; Mice; Mice, Inbred BALB C; Mitochondria; Mitoxantrone; Naphthalimides; Oxidative Phosphorylation; Oxidative Stress; Reactive Oxygen Species

2021
A Ruthenium(II) N-Heterocyclic Carbene (NHC) Complex with Naphthalimide Ligand Triggers Apoptosis in Colorectal Cancer Cells via Activating the ROS-p38 MAPK Pathway.
    International journal of molecular sciences, 2018, Dec-09, Volume: 19, Issue:12

    Topics: Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Heterocyclic Compounds; Humans; Ligands; Membrane Potential, Mitochondrial; Methane; Mitochondria; Naphthalimides; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Ruthenium; Signal Transduction

2018
Induction of apoptosis and suppression of ERCC1 expression by the potent amonafide analogue 8-c in human colorectal carcinoma cells.
    Anti-cancer drugs, 2013, Volume: 24, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Shape; Colorectal Neoplasms; Comet Assay; DNA Damage; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Endonucleases; Gene Expression Regulation, Neoplastic; Humans; Naphthalimides; Neoplasm Proteins; RNA Interference; RNA, Small Interfering; Single-Cell Analysis

2013
Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model.
    Nanomedicine : nanotechnology, biology, and medicine, 2011, Volume: 7, Issue:3

    Topics: 1-Naphthylamine; Animals; Catheterization; Cell Line, Tumor; Colorectal Neoplasms; Dendrimers; Diagnostic Imaging; Disease Models, Animal; Europium; Liver; Liver Neoplasms; Luminescence; Nanoparticles; Naphthalimides; Particle Size; Quinolones; Rats; Time Factors

2011
COX-2-independent induction of apoptosis by celecoxib and polyamine naphthalimide conjugate mediated by polyamine depression in colorectal cancer cell lines.
    International journal of colorectal disease, 2012, Volume: 27, Issue:7

    Topics: Acetyltransferases; Amino Acid Chloromethyl Ketones; Apoptosis; Caspases; Celecoxib; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase 2; Cytochromes c; Drug Synergism; Enzyme Activation; Humans; Membrane Potential, Mitochondrial; Naphthalimides; Polyamines; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Sulfonamides; Up-Regulation

2012
Amonafide in metastatic colorectal carcinoma.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:8

    Topics: Adenine; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Neoplasm Metastasis; Organophosphonates

1990